Nibblen Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 15-11-2024
- Paid Up Capital ₹ 0.50 M
as on 15-11-2024
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
as on 15-11-2024
- Revenue -7.38%
(FY 2023)
- Profit -48.76%
(FY 2023)
- Ebitda 30.03%
(FY 2023)
- Net Worth 34.63%
(FY 2023)
- Total Assets 11.08%
(FY 2023)
About Nibblen Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.50 Cr.
Pasupathy Krishnamoorthy, Venugopal Subramanyam, Kuppuswamy Sabitha, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999TN2017PTC119781
- Company No.
119781
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2017
- Date of AGM
23 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Nibblen Life Sciences Private Limited offer?
Nibblen Life Sciences Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Medical Tubes, Disposable Cannulas, Surgical & ICU Equipments, Dialysis Machine.
Who are the key members and board of directors at Nibblen Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pasupathy Krishnamoorthy  | Director | 01-Dec-2017 | Current |
| Venugopal Subramanyam | Director | 01-Dec-2017 | Current |
| Kuppuswamy Sabitha | Director | 01-Dec-2017 | Current |
| Krishnamurthy Premalatha | Director | 01-Dec-2017 | Current |
Financial Performance of Nibblen Life Sciences.
Nibblen Life Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.38% decrease. The company also saw a substantial fall in profitability, with a 48.76% decrease in profit. The company's net worth Soared by an impressive increase of 34.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nibblen Life Sciences?
In 2023, Nibblen Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vayutez Logistics Private LimitedActive 2 years 4 monthsVenugopal Subramanyam and Kuppuswamy Sabitha are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Feb 2023 | ₹1.00 Cr | Open |
Others Creation Date: 05 Sep 2020 | ₹5.00 M | Open |
How Many Employees Work at Nibblen Life Sciences?
Unlock and access historical data on people associated with Nibblen Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nibblen Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nibblen Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
